Seasonale warned by FDA for ads

Share this article:

A television commercial for Barr Pharmaceuticals's Seasonale misleads consumers by excluding risk information to make the birth control pill seem safer, U.S. health regulators warned in a letter.
The commercial suggests use of the oral contraceptive leads to only four menstrual periods a year but fails to mention frequent and sometimes substantial bleeding, the FDA said in the Dec. 29 letter.

Barr's advertisement, which was created by PACE Advertising of Parsippany, N.J., plays down the risk of irregular menstrual bleeding that can be as heavy as a regular period by suggesting it would subside with continued use of the pill, the letter said.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.